MAP2K7 and influenza: The antiviral effect of MEKi may not be limited to RV as MEK has been identified as a key pathway that directly contributes to the life cycle of influenza virus by facilitating nuclear export of viral ribonucleoprotein [72] and several studies indeed showed antiviral effect of different MEK inhibitors against influenza [73–75].